vTv Therapeutics Inc.

Vtv Therapeutics Inc.

Biotechnology • Healthcare • High Point, NC, United States • VTVT (NCM)

vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes. The company is also investing a range of molecules across various indications for chronic diseases. It has a license agreement Newsoara Biopharma Co., Ltd. to develop and commercialize phosphodiesterase type 4 inhibitors program. The company was incorporated in 2015 and is headquartered in High Point, North Carolina.

336 841 0300 3980 Premier Drive, High Point, NC 27265, United States

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

vTv Therapeutics Inc. (NASDAQ:VTVT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
MarketBeat • Jan 5
This vTv Therapeutics Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Benzinga • Jan 5
How Vtv Therapeutics Inc. (VTVT) Affects Rotational Strategy Timing - Stock Traders Daily
Stock Traders Daily • Jan 4
vTv Therapeutics (VTVT) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Yahoo Finance • Dec 24
vTv Therapeutics (NASDAQ:VTVT) Now Covered by Analysts at TD Cowen - MarketBeat
MarketBeat • Jan 5

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has vTv Therapeutics Inc. had layoffs?
No layoff events have been recorded for vTv Therapeutics Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does vTv Therapeutics Inc. have?
vTv Therapeutics Inc. has approximately 23 employees.
What industry is vTv Therapeutics Inc. in?
vTv Therapeutics Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is vTv Therapeutics Inc. a publicly traded company?
Yes, vTv Therapeutics Inc. is publicly traded under the ticker symbol VTVT on the NCM. The company has a market capitalization of approximately $0.15 billion.
Where is vTv Therapeutics Inc. headquartered?
vTv Therapeutics Inc. is headquartered in High Point, NC, United States at 3980 Premier Drive, High Point, NC 27265, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.